RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: rhinitis
Accession: DOID:4483
browse the term
Definition: A upper respiratory infectious disease which involves irritation and inflammation of the mucous membrane of the nose due to viruses, bacteria or irritants. The inflammation results in generation of excessive amounts of mucus leading to runny nose, as well as nasal congestion and post-nasal drip. (DO)
Synonyms: exact_synonym: nasal catarrh; rhinitides; runny nose
primary_id: MESH:D012220
xref: EFO:0008521 ; NCI:C34986
For additional species annotation, visit the
Alliance of Genome Resources .
G
Adam33
ADAM metallopeptidase domain 33
susceptibility
ISO
DNA:SNPs: :multiple (human)
RGD
PMID:18778489 PMID:15298558
RGD:4145378 , RGD:4145383
NCBI chr 3:138,715,428...138,736,392
Ensembl chr 3:138,724,046...138,736,347
G
Ang
angiogenin
ISO
protein:increased expression:sputum
RGD
PMID:19178538
RGD:6892723
NCBI chr15:26,786,233...26,796,883
Ensembl chr15:26,786,065...26,801,106
G
Bdkrb1
bradykinin receptor B1
ISO
RGD
PMID:12165532
RGD:5129220
NCBI chr 6:130,275,631...130,284,968
Ensembl chr 6:130,275,478...130,280,973
G
Bdkrb2
bradykinin receptor B2
ISO
RGD
PMID:1890650 PMID:11149999
RGD:4891044 , RGD:4891033
NCBI chr 6:130,237,055...130,267,205
Ensembl chr 6:130,237,255...130,267,209
G
Bdnf
brain-derived neurotrophic factor
susceptibility
IEP ISO
mRNA:increased expression:nasal cavity epithelium DNA:SNP,haplotypes: :rs10767664,rs12273539,rs962369(human)
RGD
PMID:20464992 PMID:21723144
RGD:4891116 , RGD:8655967
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657
G
C3
complement C3
ISO IEP
mRNA:increased expression:nasal cavity epithelium
RGD
PMID:20109314 PMID:17345707
RGD:5129539 , RGD:5129524
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339
G
C3ar1
complement C3a receptor 1
severity
ISO
protein:increased expression:nasal cavity
RGD
PMID:18538384
RGD:5129559
NCBI chr 4:157,747,419...157,756,609
Ensembl chr 4:157,746,089...157,776,323
G
C5ar1
complement C5a receptor 1
ISO
RGD
PMID:18538384
RGD:5129559
NCBI chr 1:86,077,309...86,088,001
G
Casp1
caspase 1
ISO
protein:increased expression:serum
RGD
PMID:12396474 PMID:20974310
RGD:5130192 , RGD:5130187
NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:10,746,333...10,882,275
G
Cat
catalase
treatment
ISO
protein:increased activity:blood,nasal cavity mucosa:
RGD
PMID:21541033
RGD:9479054
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
G
Ccl1
C-C motif chemokine ligand 1
ISO
mRNA:increased expression:nasal cavity epithelium
RGD
PMID:17982926
RGD:4145109
NCBI chr10:67,625,962...67,628,740
Ensembl chr10:67,625,962...67,628,790
G
Ccl11
C-C motif chemokine ligand 11
severity
ISO IEP
associated with Sinusitis;protein:increased expression:paranasal sinus protein:increased expression:nasal mucus mRNA:increased expression:lung, nose
RGD
PMID:17999785 PMID:16120080 PMID:16765544
RGD:4145455 , RGD:4145411 , RGD:4145462
NCBI chr10:67,525,975...67,530,576
Ensembl chr10:67,525,862...67,530,575
G
Ccl17
C-C motif chemokine ligand 17
ISO
protein:increased expression:blood, mononuclear cell
RGD
PMID:17517104
RGD:4145498
NCBI chr19:10,208,120...10,218,340
Ensembl chr19:10,208,120...10,209,895
G
Ccl19
C-C motif chemokine ligand 19
ISO
RGD
PMID:17947663
RGD:5130909
NCBI chr 5:61,759,220...61,761,164
Ensembl chr 5:61,759,220...61,772,022
G
Ccl22
C-C motif chemokine ligand 22
ISO
protein:increased expression:blood, mononuclear cell
RGD
PMID:17517104
RGD:4145498
NCBI chr19:10,263,589...10,270,359
Ensembl chr19:10,263,589...10,270,359
G
Ccl24
C-C motif chemokine ligand 24
ISO
mRNA:increased expression:nasal cavity epithelium DNA:SNPs: :179T>C, 275C>T (human)
RGD
PMID:17982926 PMID:15580493
RGD:4145109 , RGD:4891493
NCBI chr12:26,737,423...26,741,420
Ensembl chr12:26,737,439...26,750,924
G
Ccl26
C-C motif chemokine ligand 26
ISO
DNA:polymorphism: :2497T>G (human) associated with Eosinophilia;protein:increased expression:oronasal secretion (human)
RGD
PMID:15580493 PMID:24989688
RGD:4891493 , RGD:11531119
NCBI chr12:26,745,972...26,750,924
G
Ccl4
C-C motif chemokine ligand 4
ISO
RGD
PMID:19786211
RGD:5130914
NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,950,289...68,965,722
G
Ccl7
C-C motif chemokine ligand 7
ISO
RGD
PMID:17982926
RGD:4145109
NCBI chr10:67,514,095...67,515,945
Ensembl chr10:67,514,091...67,515,947
G
Ccr2
C-C motif chemokine receptor 2
susceptibility
ISO
Rhinitis, Allergic, Seasonal; DNA:SNP:cds:p.V64I (human)
RGD
PMID:17135764
RGD:4145111
NCBI chr 8:132,611,883...132,619,106
Ensembl chr 8:132,611,410...132,620,059
G
Ccr3
C-C motif chemokine receptor 3
ISO IEP
DNA:SNP:exon:51T>C (human) protein:increased expression:blood, T cell mRNA:increased expression:nose
RGD
PMID:17135764 PMID:17156343 PMID:20696593
RGD:4145111 , RGD:4145645 , RGD:4145454
NCBI chr 8:132,463,533...132,511,601
Ensembl chr 8:132,463,788...132,511,593
G
Cd14
CD14 molecule
susceptibility resistance
ISO
DNA:polymorphism:promoter:c. -159c>T (human)
RGD
PMID:20109306 PMID:16950285
RGD:4144795 , RGD:4144810
NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,608,883...28,611,292
G
Cd28
Cd28 molecule
ISO
RGD
PMID:21356099
RGD:5131612
NCBI chr 9:69,660,316...69,689,192
Ensembl chr 9:69,545,326...69,689,192
G
Cd80
Cd80 molecule
ISO
RGD
PMID:21108691
RGD:5132622
NCBI chr11:75,760,073...75,798,978
Ensembl chr11:75,760,147...75,797,540
G
Cdc42
cell division cycle 42
ISO
mRNA:increased expression:nasal turbinate
RGD
PMID:19432938
RGD:5688273
NCBI chr 5:154,838,478...154,876,629
Ensembl chr 5:154,839,631...154,876,627
G
Cftr
CF transmembrane conductance regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16083808
NCBI chr 4:47,422,084...47,694,646
Ensembl chr 4:47,526,735...47,694,643
G
Crhr1
corticotropin releasing hormone receptor 1
ISO
mRNA, protein:increased expression:nasal cavity epithelium
RGD
PMID:17597629
RGD:5130940
NCBI chr10:89,540,192...89,583,466
Ensembl chr10:89,540,192...89,583,466
G
Crhr2
corticotropin releasing hormone receptor 2
ISO
mRNA, protein:increased expression:nasal cavity epithelium
RGD
PMID:17597629
RGD:5130940
NCBI chr 4:85,553,163...85,596,203
Ensembl chr 4:85,554,268...85,596,318
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
ISO
protein:increased expression:T cell
RGD
PMID:17625281
RGD:4891512
NCBI chr 9:69,812,859...69,819,959
Ensembl chr 9:69,813,265...69,819,973
G
Cx3cl1
C-X3-C motif chemokine ligand 1
ISO
protein:increased expression:plasma
RGD
PMID:14657873
RGD:4891906
NCBI chr19:10,233,326...10,244,856
Ensembl chr19:10,233,329...10,242,999
G
Cxcl6
C-X-C motif chemokine ligand 6
ISO
protein:increased expression:nasal mucus
RGD
PMID:20659080
RGD:4892030
NCBI chr14:17,594,959...17,596,417
Ensembl chr14:17,594,959...17,596,417
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
ISO
DNA:SNP:3' utr:*1934G>A (human)
RGD
PMID:20088379
RGD:5143945
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:115,761,696...115,771,837
G
Cysltr1
cysteinyl leukotriene receptor 1
ISO
associated with Sinusitis;mRNA:increased expression:nasal cavity epithelium
RGD
PMID:17627772 PMID:16689996 PMID:15379985 PMID:18946234
RGD:4781451 , RGD:4783198 , RGD:4847512 , RGD:4888516
NCBI chr X:75,734,281...75,762,873
Ensembl chr X:75,734,270...75,763,050
G
Cysltr2
cysteinyl leukotriene receptor 2
ISO
associated with Sinusitis;mRNA:increased expression:nasal cavity epithelium
RGD
PMID:16689996
RGD:4783198
NCBI chr15:54,599,043...54,638,314
Ensembl chr15:54,598,818...54,713,597
G
Fcer1a
Fc epsilon receptor Ia
ISO
RGD
PMID:20650300
RGD:5128714
NCBI chr13:88,218,427...88,224,723
Ensembl chr13:88,218,420...88,224,681
G
Fis1
fission, mitochondrial 1
IEP
mRNA, protein:increased expression:nasal cavity mucosa (rat)
RGD
PMID:28146064
RGD:13204839
NCBI chr12:25,345,239...25,360,135
Ensembl chr12:25,345,239...25,349,335
G
Hdc
histidine decarboxylase
ISO IEP
DNA:SNP: :p.E644D (rs2073440) (human)
RGD
PMID:20608921 PMID:15054596
RGD:5128884 , RGD:5143921
NCBI chr 3:134,300,628...134,318,704
Ensembl chr 3:134,300,632...134,318,711
G
Hnmt
histamine N-methyltransferase
no_association
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17651147 PMID:17651147
RGD:5128885
NCBI chr 3:26,978,274...27,010,291
Ensembl chr 3:26,977,933...27,010,482
G
Hrh1
histamine receptor H 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12167471
NCBI chr 4:149,120,511...149,204,267
Ensembl chr 4:149,120,039...149,208,248
G
Il13
interleukin 13
susceptibility disease_progression
ISO IEP
associated with asthma; DNA:polymorphisms:promoter:c. -1510A>C, -1055C>T (human) mRNA:increased expression:nose DNA:polymorphism: :rs1800925 (human)
RGD
PMID:16120094 PMID:20358028 PMID:20696593 PMID:17088137 PMID:20484924
RGD:4206706 , RGD:4145767 , RGD:4145454 , RGD:4159171 , RGD:4145534
NCBI chr10:38,290,926...38,293,483
Ensembl chr10:38,290,926...38,293,483
G
Il13ra2
interleukin 13 receptor subunit alpha 2
ISO
RGD
PMID:17088137
RGD:4159171
NCBI chr X:115,814,620...115,886,080
Ensembl chr X:115,814,622...115,841,455
G
Il15
interleukin 15
ISO
RGD
PMID:16750998
RGD:5000756
NCBI chr19:42,536,160...42,611,349
Ensembl chr19:42,545,346...42,611,348
G
Il16
interleukin 16
ISO
protein:increased expression:serum protein:increased expression:nasal cavity epithelium, serum
RGD
PMID:18254318 PMID:19295235
RGD:5024932 , RGD:5024931
NCBI chr 1:147,026,852...147,127,177
Ensembl chr 1:147,027,097...147,127,023
G
Il17a
interleukin 17A
ISO
protein:increased expression:nasal mucosa
RGD
PMID:20506642 PMID:19927541
RGD:4889137 , RGD:4889144
NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:30,640,844...30,644,331
G
Il18
interleukin 18
disease_progression
ISO
protein:increased expression:nasal lavage fluid, bronchoalveolar lavage fluid rhinitis allergic, seasonal; protein:increased expression:plasma protein:increased expression:serum
RGD
PMID:17305282 PMID:15934281 PMID:17323858
RGD:4889917 , RGD:4889927 , RGD:4889916
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286
G
Il1b
interleukin 1 beta
susceptibility
IEP ISO
mRNA:increased expression:nasal cavity epithelium associated with Hypersensitivity;DNA:polymorphism: :-511C>T (human) associated with Hypersensitivity;protein:increased expression:nasal mucus
RGD
PMID:20490816 PMID:14533660 PMID:10224452
RGD:4142821 , RGD:4142859 , RGD:4143227
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
G
Il1rl1
interleukin 1 receptor-like 1
severity
ISO
associated with Sinusitis;DNA:SNPs: :multiple (human)
RGD
PMID:19671251
RGD:5144228
NCBI chr 9:50,157,326...50,222,888
Ensembl chr 9:50,204,551...50,222,891
G
Il1rn
interleukin 1 receptor antagonist
susceptibility
ISO
associated with Hypersensitivity;DNA:repeat:intron (human)
RGD
PMID:14533660 PMID:15178892 PMID:10224452
RGD:4142859 , RGD:4143215 , RGD:4143227
NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:27,509,798...27,525,732
G
Il2
interleukin 2
susceptibility
ISO
DNA:SNP:promoter:rs2069762(human)
RGD
PMID:16333313
RGD:8663473
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672
G
Il21
interleukin 21
ISO
RGD
PMID:17982108
RGD:5147397
NCBI chr 2:122,045,240...122,055,142
Ensembl chr 2:122,045,240...122,055,142
G
Il22
interleukin 22
severity
ISO
mRNA:increased expression:blood, mononuclear cell
RGD
PMID:21535180
RGD:5147409
NCBI chr 7:55,687,061...55,691,526
Ensembl chr 7:55,686,896...55,692,201
G
Il23r
interleukin 23 receptor
susceptibility
ISO
DNA:SNP,haplotype: :rs7517847(human)
RGD
PMID:23696856
RGD:8549605
NCBI chr 4:97,910,230...98,003,759
Ensembl chr 4:97,909,972...98,004,110
G
Il27ra
interleukin 27 receptor subunit alpha
ISO
RGD
PMID:19354069
RGD:5128480
NCBI chr19:41,014,730...41,026,740
Ensembl chr19:41,014,730...41,026,760
G
Il4
interleukin 4
ISO IEP
mRNA:increased expression:nasal cavity epithelium CTD Direct Evidence: marker/mechanism protein:increased expression:serum
CTD RGD
PMID:19672097 PMID:21208219 PMID:18826099
RGD:5128558 , RGD:2317285
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549
G
Il4r
interleukin 4 receptor
ISO
DNA:polymorphism: :c.1432T>C (human)
RGD
PMID:15564773
RGD:4890394
NCBI chr 1:189,545,739...189,570,639
Ensembl chr 1:189,544,988...189,570,636
G
Il5
interleukin 5
ISO
RGD
PMID:11884474
RGD:5128622
NCBI chr10:38,375,132...38,378,003
Ensembl chr10:38,375,132...38,378,003
G
Il9
interleukin 9
ISO
RGD
PMID:20525149
RGD:5128687
NCBI chr17:8,117,028...8,120,151
Ensembl chr17:8,117,028...8,120,151
G
Lep
leptin
ISO
RGD
PMID:19860581
RGD:5128850
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:58,626,523...58,640,661
G
Mbl2
mannose binding lectin 2
susceptibility
ISO
DNA:polymorphism: :
RGD
PMID:18831943
RGD:8693717
NCBI chr 1:237,429,873...237,465,567
Ensembl chr 1:237,429,973...237,437,546
G
Mfn1
mitofusin 1
IEP
mRNA, protein:increased expression:nasal cavity mucosa (rat)
RGD
PMID:28146064
RGD:13204839
NCBI chr 2:117,240,525...117,288,017
Ensembl chr 2:117,241,759...117,290,190
G
Mif
macrophage migration inhibitory factor
severity
ISO
protein:increased expression:serum, nasal mucosa
RGD
PMID:15053202 PMID:15922619
RGD:4891045 , RGD:4891056
NCBI chr20:12,767,138...12,791,222
Ensembl chr 4:134,041,774...134,042,121 Ensembl chr20:134,041,774...134,042,121
G
Ms4a2
membrane spanning 4-domains A2
ISO
RGD
PMID:15480314
RGD:5131152
NCBI chr 1:217,864,855...217,873,934
Ensembl chr 1:217,865,159...217,873,108
G
Muc5ac
mucin 5AC, oligomeric mucus/gel-forming
IEP ISO
mRNA:increased expression:nose
RGD
PMID:20696593 PMID:15715404
RGD:4145454 , RGD:7364740
NCBI chr 1:206,293,717...206,326,006
Ensembl chr 1:206,293,869...206,326,006
G
Ngf
nerve growth factor
ISO
protein:increased expression:respiratory system fluid/secretion associated with Sinusitis;protein:increased expression:respiratory system mucosa
RGD
PMID:10224365 PMID:19958603
RGD:4891115 , RGD:4891064
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:192,589,582...192,643,834
G
Ngfr
nerve growth factor receptor
ISO
protein:increased expression:blood, eosinophil
RGD
PMID:18647313
RGD:5144116
NCBI chr10:81,012,077...81,030,305
Ensembl chr10:81,012,089...81,030,305
G
Nod1
nucleotide-binding oligomerization domain containing 1
ISO
mRNA:decreased expression:nose
RGD
PMID:20384614
RGD:5131446
NCBI chr 4:85,391,142...85,442,281
Ensembl chr 4:85,391,151...85,441,674
G
Nod2
nucleotide-binding oligomerization domain containing 2
susceptibility
ISO
DNA:polymorphisms:cds:2104C>T,2722G>C (human)
RGD
PMID:12704363
RGD:5131484
NCBI chr19:34,555,832...34,596,281
Ensembl chr19:34,555,832...34,722,846
G
Nos2
nitric oxide synthase 2
ISO
protein:increased expression:nasal mucosa
RGD
PMID:18254476
RGD:4891910
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
G
Npy
neuropeptide Y
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12746121
NCBI chr 4:80,212,111...80,219,310
Ensembl chr 4:80,212,111...80,219,310
G
Ntrk1
neurotrophic receptor tyrosine kinase 1
ISO
protein:increased expression:eosinophil
RGD
PMID:18647313
RGD:5144116
NCBI chr 2:175,534,844...175,551,664
Ensembl chr 2:175,534,844...175,551,787
G
Opa1
OPA1, mitochondrial dynamin like GTPase
IEP
mRNA, protein:increased expression:nasal cavity mucosa (rat)
RGD
PMID:28146064
RGD:13204839
NCBI chr11:84,612,943...84,690,025
Ensembl chr11:84,615,340...84,689,955
G
Plau
plasminogen activator, urokinase
ISO
mRNA:increased expression:nasal cavity epithelium
RGD
PMID:21339035
RGD:8547809
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030
G
Ptgdr2
prostaglandin D2 receptor 2
ISO
RGD
PMID:19230460 PMID:19608418
RGD:5135021 , RGD:5135017
NCBI chr 1:217,010,183...217,015,044
Ensembl chr 1:216,995,629...217,022,393
G
RT1-Ba
RT1 class II, locus Ba
susceptibility
ISO
DNA:polymorphisms:cds:HLA-DQA1*0201, HLA-DQA1*0302 (human)
RGD
PMID:14990915
RGD:5147798
NCBI chr20:4,577,057...4,581,650
Ensembl chr20:4,576,843...4,581,653
G
RT1-Bb
RT1 class II, locus Bb
susceptibility
ISO
DNA:polymorphism:cds:HLA-DQB1*0602 (human)
RGD
PMID:14990915
RGD:5147798
NCBI chr20:4,598,475...4,604,118
Ensembl chr20:4,598,475...4,604,118
G
Scgb3a2
secretoglobin, family 3A, member 2
ISO
protein:increased expression:sputum mRNA,protein:decreased expression:nasal mucosa
RGD
PMID:17218572 PMID:21385388
RGD:5144232 , RGD:5147389
NCBI chr18:36,183,745...36,186,667
Ensembl chr18:36,183,698...36,186,742
G
Serpine1
serpin family E member 1
susceptibility
ISO
DNA:polymorphism:promoter:rs1799768 (human)
RGD
PMID:19063817
RGD:4144832
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357
G
Sftpd
surfactant protein D
susceptibility
ISO
associated with Hypersensitivity;DNA:polymorphism: :p.M11T (human)
RGD
PMID:19493231
RGD:4143494
NCBI chr16:17,080,575...17,093,047
Ensembl chr16:17,080,567...17,094,036
G
Tap1
transporter 1, ATP binding cassette subfamily B member
susceptibility no_association
ISO
DNA:SNPs: :
RGD
PMID:17982230 PMID:12018331
RGD:6482262 , RGD:6482274
NCBI chr20:4,658,171...4,668,543
Ensembl chr20:4,658,172...4,668,810
G
Tbxa2r
thromboxane A2 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12167471
NCBI chr 7:9,034,077...9,041,489
Ensembl chr 7:9,034,108...9,038,905
G
Tgfb1
transforming growth factor, beta 1
ISO
associated with Sinusitis
RGD
PMID:18423831
RGD:4145277
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
G
Tlr2
toll-like receptor 2
susceptibility no_association
ISO
DNA:SNPs: :597T>C, 1350T>C (human) mRNA:decreased expression:nasal mucosa: associated with Sinusitis;DNA:SNPs: :multiple (human)
RGD
PMID:19763595 PMID:18219831 PMID:19128592
RGD:4145354 , RGD:7800742 , RGD:4145356
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:171,497,060...171,520,194
G
Tlr6
toll-like receptor 6
ISO
associated with Asthma;DNA:SNP: :rs2381289 (human)
RGD
PMID:20815312
RGD:4145352
NCBI chr14:43,715,809...43,727,019
Ensembl chr14:43,698,751...43,740,462
G
Tnf
tumor necrosis factor
ISO IEP
mRNA:increased expression:nose
RGD
PMID:15120189 PMID:20696593
RGD:4143470 , RGD:4145454
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
G
Vegfa
vascular endothelial growth factor A
ISO
protein:increased expression:sputum
RGD
PMID:19178538
RGD:6892723
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
G
Vip
vasoactive intestinal peptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12746121 PMID:14680090
NCBI chr 1:44,470,232...44,478,561
Ensembl chr 1:44,470,462...44,478,558
G
Abcb1a
ATP binding cassette subfamily B member 1A
severity
ISO
DNA:snp:exon:c.1236C>T (human)
RGD
PMID:24040855
RGD:8657076
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135
G
Ace
angiotensin I converting enzyme
no_association
ISO
DNA:deletion:intron:IVS16+1464-1751del (human)
RGD
PMID:15112973
RGD:8142345
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:91,409,819...91,430,942
G
Bcl2
BCL2, apoptosis regulator
IEP
mRNA, protein:increased expression:nasal mucosa (rat)
RGD
PMID:15362690
RGD:11522724
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
G
Cat
catalase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29028686
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
G
Ccl11
C-C motif chemokine ligand 11
treatment
IDA
RGD
PMID:23089405
RGD:7248414
NCBI chr10:67,525,975...67,530,576
Ensembl chr10:67,525,862...67,530,575
G
Ccl26
C-C motif chemokine ligand 26
ISO
protein:increased expression:oronasal secretion (human)
RGD
PMID:23883806
RGD:7364793
NCBI chr12:26,745,972...26,750,924
G
Cd40
CD40 molecule
ISO
protein:increased expression:lymphocyte
RGD
PMID:19086656
RGD:8547782
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:174,209,719...174,224,847
G
Cd40lg
CD40 ligand
ISO
protein:increased expression:lymphocyte
RGD
PMID:19086656
RGD:8547782
NCBI chr X:140,164,341...140,176,057
Ensembl chr X:140,164,302...140,176,475
G
Cldn3
claudin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33441633
NCBI chr12:27,345,075...27,346,547
Ensembl chr12:27,345,076...27,348,841
G
Cldn7
claudin 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33441633
NCBI chr10:55,188,670...55,190,871
Ensembl chr10:55,188,684...55,190,905
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
treatment
ISO
RGD
PMID:10436391
RGD:11344920
NCBI chr 9:69,812,859...69,819,959
Ensembl chr 9:69,813,265...69,819,973
G
F2
coagulation factor II, thrombin
ISO
protein:increased expression:nasal mucus
RGD
PMID:21711961
RGD:5147783
NCBI chr 3:98,051,958...98,065,246
Ensembl chr 3:98,051,960...98,065,246
G
Fcgr3a
Fc gamma receptor 3A
susceptibility
ISO
DNA:polymorphism:exon:p.F158V(rs396991)(human)
RGD
PMID:18199088
RGD:5508449
NCBI chr13:85,782,636...85,792,656
Ensembl chr13:85,782,490...85,792,651
G
Flg
filaggrin
susceptibility
ISO
associated with atopic dermatitis;DNA:SNP:cds:p.P478S (rs11584340)
RGD
PMID:21219289
RGD:628398356
NCBI chr 2:181,583,801...181,596,464
Ensembl chr 2:181,583,808...181,595,968
G
Gria1
glutamate ionotropic receptor AMPA type subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34624383
NCBI chr10:41,710,540...42,030,105
Ensembl chr10:41,711,080...42,030,309
G
Gria2
glutamate ionotropic receptor AMPA type subunit 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34624383
NCBI chr 2:168,247,490...168,367,616
Ensembl chr 2:168,247,496...168,367,616
G
Hmox1
heme oxygenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36127783
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
G
Hrh1
histamine receptor H 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23333628
NCBI chr 4:149,120,511...149,204,267
Ensembl chr 4:149,120,039...149,208,248
G
Ifng
interferon gamma
treatment
ISO IDA
associated with Asthma CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:29871060 PMID:12787306 PMID:18510219
RGD:7829803 , RGD:10755770
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
G
Ighe
immunoglobulin heavy constant epsilon
ISO
DNA:mutations:cds:
RGD
PMID:25171866
RGD:629006504
G
Il10
interleukin 10
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:36127783 PMID:23883806 PMID:23253209
RGD:7364793 , RGD:7364818
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
G
Il13
interleukin 13
susceptibility no_association
ISO
DNA:polymorphism:exon:c. 2044G>A (human) CTD Direct Evidence: marker/mechanism DNA:missense mutation:cds:p.R130Q (rs20541) (human) DNA:SNPs:promoter, cds:-1112C>T, p.R130Q (rs1800925, rs20541) (human) DNA:SNP:promoter:-1512A>C (rs1881457) (human)
CTD OMIM RGD
PMID:17091279 PMID:22852128 PMID:12928861 PMID:23996716
RGD:4152796 , RGD:8549518 , RGD:8549516 , RGD:8549501
NCBI chr10:38,290,926...38,293,483
Ensembl chr10:38,290,926...38,293,483
G
Il13ra2
interleukin 13 receptor subunit alpha 2
ISO
protein:increased expression:serum
RGD
PMID:21462799
RGD:8549521
NCBI chr X:115,814,620...115,886,080
Ensembl chr X:115,814,622...115,841,455
G
Il17a
interleukin 17A
susceptibility
ISO
DNA:snp:promoter:c.-444A>G (human) mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:22507625 PMID:21535180
RGD:9068429 , RGD:5147409
NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:30,640,844...30,644,331
G
Il18
interleukin 18
severity no_association
ISO
DNA:SNP:promoter:-137G>C (rs187238) (human) DNA:SNP:promoter:-140C>G (rs360721) (human)
RGD
PMID:22840759 PMID:22840759
RGD:8655914 , RGD:8655914
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286
G
Il1b
interleukin 1 beta
ISO
protein:increased expression:nasal mucus
RGD
PMID:7750009
RGD:7401199
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
G
Il2
interleukin 2
IEP
RGD
PMID:12592663
RGD:8662963
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672
G
Il4
interleukin 4
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:36127783 PMID:9893928 PMID:24620662 PMID:8908280 PMID:14653048
RGD:7829796 , RGD:11522769 , RGD:7829827 , RGD:7829802
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549
G
Il5
interleukin 5
treatment
IEP
RGD
PMID:23934070 PMID:24620662
RGD:11354976 , RGD:11522769
NCBI chr10:38,375,132...38,378,003
Ensembl chr10:38,375,132...38,378,003
G
Itgb2
integrin subunit beta 2
treatment
IEP
RGD
PMID:12046991
RGD:9698435
NCBI chr20:11,061,009...11,097,242
Ensembl chr20:11,058,492...11,097,182
G
Ltc4s
leukotriene C4 synthase
ISO
DNA:SNP:promoter:g.-444A>C
RGD
PMID:16730545
RGD:626168264
NCBI chr10:35,060,002...35,066,466
Ensembl chr10:35,061,437...35,063,768
G
Mrc1
mannose receptor, C type 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36127783
NCBI chr17:82,157,725...82,239,411
Ensembl chr17:82,157,705...82,239,410
G
Muc1
mucin 1, cell surface associated
severity
ISO IMP IEP
mRNA,protein:decreased expression:nasal mucosa
RGD
PMID:31425778 PMID:31425778 PMID:31425778
RGD:127345100 , RGD:127345100 , RGD:127345100
NCBI chr 2:176,933,312...176,938,497
Ensembl chr 2:176,933,047...176,938,491
G
Muc1em1Cgen
mucin 1, cell surface associated; TALEN induced mutant 1, Cgen
severity
IMP
RGD
PMID:31425778
RGD:127345100
G
Muc5ac
mucin 5AC, oligomeric mucus/gel-forming
IEP
mRNA, protein:increased expression:nasal cavity epithelium
RGD
PMID:22972875
RGD:7364746
NCBI chr 1:206,293,717...206,326,006
Ensembl chr 1:206,293,869...206,326,006
G
Nod2
nucleotide-binding oligomerization domain containing 2
ISO
mRNA:increased expression:nasal mucosa (human)
RGD
PMID:23858718
RGD:8547523
NCBI chr19:34,555,832...34,596,281
Ensembl chr19:34,555,832...34,722,846
G
Ocln
occludin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33441633
NCBI chr 2:33,391,303...33,442,207
Ensembl chr 2:33,391,303...33,430,411
G
Pon1
paraoxonase 1
severity
ISO
protein:decreased activity:plasma (human)
RGD
PMID:23406590
RGD:8547583
NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:34,261,289...34,287,924
G
Prkg1
protein kinase cGMP-dependent 1
IEP
protein:increased expression:nasal cavity epithelium
RGD
PMID:24012634
RGD:7775060
NCBI chr 1:237,818,950...239,052,184
Ensembl chr 1:237,823,053...239,103,005
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16979129
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
G
Rora
RAR-related orphan receptor A
ameliorates
ISO
DNA:SNP:multiple:multiple
RGD
PMID:35636076
RGD:626469566
NCBI chr 8:78,182,710...78,915,730
Ensembl chr 8:78,182,620...78,915,730
G
RT1-M3-1
RT1 class Ib, locus M3, gene 1
ISO
RGD
PMID:20487636
RGD:5144132
NCBI chr20:1,329,227...1,333,394
Ensembl chr20:1,329,225...1,333,366
G
Scgb1a1
secretoglobin family 1A member 1
ISO
mRNA:decreased expression:nasal mucosa, lung
RGD
PMID:17882576
RGD:5144135
NCBI chr 1:215,406,138...215,409,686
Ensembl chr 1:215,406,138...215,409,686
G
Scgb3a2
secretoglobin, family 3A, member 2
susceptibility
ISO
DNA:SNP: :rs7726552 (human)
RGD
PMID:21410962
RGD:5144225
NCBI chr18:36,183,745...36,186,667
Ensembl chr18:36,183,698...36,186,742
G
Serpine1
serpin family E member 1
ISO
mRNA:increased expression:nasal mucosa (mouse)
RGD
PMID:21339035
RGD:8547809
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357
G
Tacr1
tachykinin receptor 1
IEP
mRNA:increased expression:nasal mucosa
RGD
PMID:12768696
RGD:5147835
NCBI chr 4:116,478,617...116,647,492
Ensembl chr 4:116,478,617...116,647,492
G
Tgfb1
transforming growth factor, beta 1
treatment
IEP
RGD
PMID:31368266
RGD:14995445
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
G
Tlr2
toll-like receptor 2
severity
ISO
DNA:polymorphism:cds:p.R753Q(human) protein:increased expression:neutrophil: mRNA:decreased expression:nasal mucosa:
RGD
PMID:22402138 PMID:22555057 PMID:18381801 PMID:18219831
RGD:7800732 , RGD:8552993 , RGD:8552972 , RGD:7800742
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:171,497,060...171,520,194
G
Tlr4
toll-like receptor 4
severity treatment susceptibility no_association
ISO
DNA:polymorphism:cds:p.D299G(human) protein:increased expression:nasal lavage,leukocyte, bone marrow: protein:decreased expression:nasal mucosa: DNA:SNP: :rs1927911(human) DNA:polymorphism: :4216G>C(human)
RGD
PMID:22402138 PMID:22555057 PMID:22577387 PMID:17069098 PMID:23639307 PMID:19763595 More...
RGD:7800732 , RGD:8552993 , RGD:7800740 , RGD:7800738 , RGD:7800736 , RGD:4145354
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
G
Tlr9
toll-like receptor 9
ISO
protein:decreased expression:nasal mucosa:
RGD
PMID:22577387
RGD:7800740
NCBI chr 8:115,743,407...115,747,523
Ensembl chr 8:115,742,889...115,750,148
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
treatment
ISO
associated with Eosinophilic Esophagitis; DNA:polymorphisms::
RGD
PMID:26416193
RGD:11352743
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798
G
Il3
interleukin 3
susceptibility
ISO
DNA:SNP: :rs40401(human)
RGD
PMID:23953855
RGD:13506915
NCBI chr10:38,906,460...38,908,810
Ensembl chr10:38,906,460...38,908,810
G
Edn1
endothelin 1
ISO
protein:increased expression:inferior turbinate, nasal gland, inflammatory cell (human)
RGD
PMID:8845175
RGD:8661738
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687
G
Cd8a
CD8 subunit alpha
ameliorates
ISO
protein:decreased expression:blood, T cell (human)
RGD
PMID:24639246
RGD:124715444
NCBI chr 4:104,924,116...104,928,353
Ensembl chr 4:104,900,833...104,928,358
G
Cdhr3
cadherin-related family member 3
ISO
DNA:SNP:intron:rs6967330
RGD
PMID:34076350
RGD:626467892
NCBI chr 6:55,369,215...55,429,454
Ensembl chr 6:55,369,851...55,429,458
G
Glcci1
glucocorticoid induced 1
treatment
ISO
DNA:SNP: :rs37973
RGD
PMID:30256538
RGD:628359914
NCBI chr 4:37,274,271...37,601,898
Ensembl chr 4:37,529,364...37,599,802 Ensembl chr 4:37,529,364...37,599,802
G
Il17a
interleukin 17A
ISO
protein:increased expression:uncinate process, nasal mucosa (human)
RGD
PMID:23613503
RGD:8696039
NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:30,640,844...30,644,331
G
Il1rn
interleukin 1 receptor antagonist
susceptibility
ISO
DNA:repeats:intron:IVS2+914_1000dup I/II alleles (human)
RGD
PMID:16549749
RGD:8549791
NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:27,509,798...27,525,732
G
Ltc4s
leukotriene C4 synthase
ISO
mRNA:increased expression:sinonasal mucosa
RGD
PMID:15940133
RGD:626168282
NCBI chr10:35,060,002...35,066,466
Ensembl chr10:35,061,437...35,063,768
G
Mbl2
mannose binding lectin 2
ISO
protein:decreased activity:serum:
RGD
PMID:23144819
RGD:8693716
NCBI chr 1:237,429,873...237,465,567
Ensembl chr 1:237,429,973...237,437,546
G
Prg2
proteoglycan 2, pro eosinophil major basic protein
disease_progression
ISO
associated with Nasal Polyps;
RGD
PMID:24450586
RGD:13506943
NCBI chr 3:90,469,192...90,472,759
Ensembl chr 3:90,469,176...90,472,752
G
Alox5
arachidonate 5-lipoxygenase
treatment
ISO
RGD
PMID:23751068
RGD:626419675
NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:151,203,949...151,251,126
G
Glcci1
glucocorticoid induced 1
treatment
ISO
DNA:SNP: :rs37973
RGD
PMID:30256538
RGD:628359914
NCBI chr 4:37,274,271...37,601,898
Ensembl chr 4:37,529,364...37,599,802 Ensembl chr 4:37,529,364...37,599,802
G
Il4
interleukin 4
treatment
ISO
RGD
PMID:23751068
RGD:626419675
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549
G
Il5
interleukin 5
treatment
ISO
RGD
PMID:23751068
RGD:626419675
NCBI chr10:38,375,132...38,378,003
Ensembl chr10:38,375,132...38,378,003
G
Ltc4s
leukotriene C4 synthase
treatment
ISO
RGD
PMID:23751068
RGD:626419675
NCBI chr10:35,060,002...35,066,466
Ensembl chr10:35,061,437...35,063,768
G
Ptgds
prostaglandin D2 synthase
treatment
ISO
RGD
PMID:23751068
RGD:626419675
NCBI chr 3:28,680,044...28,682,978
Ensembl chr 3:28,680,044...28,682,978
G
Ptgs2
prostaglandin-endoperoxide synthase 2
treatment
ISO
RGD
PMID:23751068
RGD:626419675
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
G
Spink5
serine peptidase inhibitor, Kazal type 5
ISO
mRNA, protein:decreased expression:nasal cavity mucosa associated with aspirin-induced respiratory disease;mRNA:decreased expression:nasal cavity mucosa
RGD
PMID:18588753 PMID:22570283
RGD:628359029 , RGD:628359036
NCBI chr18:36,515,347...36,584,038
Ensembl chr18:36,515,347...36,583,799
G
Csta
cystatin A
ISO
mRNA, protein:decreased expression:nasal cavity epithelium protein:decreased expression:nose, oronasal secretion
RGD
PMID:27779422 PMID:27779422
RGD:628359037 , RGD:628359037
NCBI chr11:78,125,813...78,136,818
Ensembl chr11:78,125,800...78,136,822
G
Glcci1
glucocorticoid induced 1
treatment
ISO
DNA:SNP: :rs37973
RGD
PMID:30256538
RGD:628359914
NCBI chr 4:37,274,271...37,601,898
Ensembl chr 4:37,529,364...37,599,802 Ensembl chr 4:37,529,364...37,599,802
G
Spink5
serine peptidase inhibitor, Kazal type 5
ISO
mRNA, protein:decreased expression:nasal cavity epithelium protein:decreased expression:nose, oronasal secretion
RGD
PMID:27779422 PMID:27779422
RGD:628359037 , RGD:628359037
NCBI chr18:36,515,347...36,584,038
Ensembl chr18:36,515,347...36,583,799
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
protein:decreased expression:serum
RGD
PMID:19725899
RGD:5686851
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169
G
Alb
albumin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19389874
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
G
Alox5ap
arachidonate 5-lipoxygenase activating protein
ISO
protein:increased expression:nasal turbinate
RGD
PMID:19364335
RGD:5147461
NCBI chr12:10,785,254...10,809,295
Ensembl chr12:10,785,257...10,817,038
G
Cat
catalase
ISO
protein:decreased expression:plasma
RGD
PMID:20493834
RGD:5130771
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
G
Ccl2
C-C motif chemokine ligand 2
ISO
protein:increased expression:nasal turbinate, mucosa (human)
RGD
PMID:9865755
RGD:8548839
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
G
Ccr2
C-C motif chemokine receptor 2
ISO
mRNA:increased expression:Nasal Mucosa
RGD
PMID:17982926
RGD:4145109
NCBI chr 8:132,611,883...132,619,106
Ensembl chr 8:132,611,410...132,620,059
G
Ccr5
C-C motif chemokine receptor 5
ISO
mRNA:increased expression:nasal mucosa (human)
RGD
PMID:17982926
RGD:4145109
NCBI chr 8:132,629,097...132,660,980
Ensembl chr 8:132,629,683...132,637,594
G
Cd40
CD40 molecule
ISO
RGD
PMID:20226305
RGD:5132269
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:174,209,719...174,224,847
G
Cd86
CD86 molecule
ISO
protein:increased expression:nasal mucosa, dendritic cell (human)
RGD
PMID:17088138
RGD:4892343
NCBI chr11:77,647,565...77,706,178
Ensembl chr11:77,647,600...77,725,361
G
Chia
chitinase, acidic
ISO
mRNA, protein:increased expression:turbinate, mucosa (human)
RGD
PMID:20422678
RGD:5037226
NCBI chr 2:196,302,687...196,344,849
Ensembl chr 2:196,302,545...196,344,850
G
Egr1
early growth response 1
ISO
DNA:snp:5' utr:g.-4071A>G rs7729723 (human)
RGD
PMID:19833116
RGD:5131984
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843
G
F2rl1
F2R like trypsin receptor 1
ISO
RGD
PMID:17727088
RGD:4892590
NCBI chr 2:28,507,003...28,519,954
Ensembl chr 2:28,507,003...28,519,954
G
Gstp1
glutathione S-transferase pi 1
susceptibility
ISO
DNA:polymorphism:exon:p.I105V (rs1695) (human)
RGD
PMID:17181111
RGD:4142523
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705
G
Hmox1
heme oxygenase 1
ISO
mRNA, protein:increased expression: nasal mucosa
RGD
PMID:16540907
RGD:4145406
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
G
Icam1
intercellular adhesion molecule 1
ISO
protein:increased expression:lung, endothelium (mouse) protein:increased secretion:nasopharynx (human)
RGD
PMID:19968652 PMID:19047814
RGD:4145464 , RGD:4145520
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
G
Ifngr1
interferon gamma receptor 1
ISO
DNA: SNP: Leu467Pro
RGD
PMID:12851715
RGD:6480431
NCBI chr 1:16,152,811...16,171,439
Ensembl chr 1:16,152,879...16,171,437
G
Il13
interleukin 13
ISO
mRNA, protein:increased expression:nasal mucosa
RGD
PMID:8520776
RGD:4782826
NCBI chr10:38,290,926...38,293,483
Ensembl chr10:38,290,926...38,293,483
G
Il17a
interleukin 17A
severity
ISO
protein:increased expression:serum
RGD
PMID:19226302
RGD:4889151
NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:30,640,844...30,644,331
G
Il18
interleukin 18
susceptibility
ISO
DNA:SNP:promoter:c. -607A>C (rs1946518) (human)
RGD
PMID:16406079
RGD:4889924
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286
G
Il1a
interleukin 1 alpha
ISO
DNA:polymorphism:exon:c.4845G>T (human)
RGD
PMID:14533660
RGD:4142859
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013
G
Il1r1
interleukin 1 receptor type 1
ISO
RGD
PMID:18637763
RGD:5037238
NCBI chr 9:50,000,558...50,076,579
Ensembl chr 9:50,000,566...50,076,579
G
Il2
interleukin 2
ISO
protein:decreased expression:serum:
RGD
PMID:17608155
RGD:8662959
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672
G
Il4
interleukin 4
treatment
ISO
protein:increased expression:serum
RGD
PMID:21171297 PMID:9237816 PMID:15329007
RGD:5128559 , RGD:7829817 , RGD:7829804
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549
G
Il5
interleukin 5
ISO
protein: increased levels: sputum
RGD
PMID:22186238
RGD:5687140
NCBI chr10:38,375,132...38,378,003
Ensembl chr10:38,375,132...38,378,003
G
Mmp2
matrix metallopeptidase 2
ISO
protein:increased expression:nasal mucosa:
RGD
PMID:19786210
RGD:5130872
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856
G
Mmp9
matrix metallopeptidase 9
ISO
protein:increased expression:nasal mucosa:
RGD
PMID:19786210
RGD:5130872
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
G
Nos2
nitric oxide synthase 2
ISO
protein:increased expression:nasal mucosa
RGD
PMID:14587983
RGD:4892078
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
G
Nos3
nitric oxide synthase 3
ISO
DNA:snp:promoter:g.-786T>C (human)
RGD
PMID:18086269
RGD:4892054
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
ISO
protein:altered expression:nasal mucosa
RGD
PMID:20185258
RGD:4892593
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843
G
Pparg
peroxisome proliferator-activated receptor gamma
ISO
mRNA, protein:increased expression:nasal mucosa (human)
RGD
PMID:17116814
RGD:8552811
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
G
Ptgs1
prostaglandin-endoperoxide synthase 1
ISO
protein:increased expression:respiratory system epithelium
RGD
PMID:19364335
RGD:5147461
NCBI chr 3:39,981,419...40,002,993
Ensembl chr 3:39,981,415...40,002,990
G
Tbxa2r
thromboxane A2 receptor
treatment
ISO
RGD
PMID:15247523
RGD:11059532
NCBI chr 7:9,034,077...9,041,489
Ensembl chr 7:9,034,108...9,038,905
G
Anxa1
annexin A1
ISO
associated with Nasal Polyps
RGD
PMID:22279949
RGD:7421555
NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:227,287,717...227,306,831
G
C3
complement C3
ISO
protein:increased expression:serum
RGD
PMID:19593977
RGD:4889484
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339
G
C4a
complement C4A (Rodgers blood group)
disease_progression
ISO
DNA:deletion: :
RGD
PMID:16879240
RGD:5688262
NCBI chr20:4,010,306...4,024,707
G
Ccl20
C-C motif chemokine ligand 20
ISO
RGD
PMID:16702571
RGD:7483585
NCBI chr 9:91,837,139...91,839,736
Ensembl chr 9:91,836,946...91,839,736
G
Hgf
hepatocyte growth factor
susceptibility
ISO
DNA:haplotype::rs38850,rs38855,rs38857(human)
RGD
PMID:20416453
RGD:8548615
NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:19,632,267...19,700,851
G
Igf1
insulin-like growth factor 1
ISO
mRNA:increased expression:nose:
RGD
PMID:20713758
RGD:8548883
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764
G
Il10
interleukin 10
ISO
protein:decreased expression:blood, mononuclear cell
RGD
PMID:23168151
RGD:7364820
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
G
Il17a
interleukin 17A
ISO
associated with Asthma;mRNA, protein:increased expression:nasal polyps (human)
RGD
PMID:19672092
RGD:4889146
NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:30,640,844...30,644,331
G
Il1b
interleukin 1 beta
ISO
protein:increased expression:nasal cavity epithelium
RGD
PMID:11197112
RGD:7401169
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
G
Il22ra1
interleukin 22 receptor subunit alpha 1
susceptibility
ISO
DNA:SNPs:5' utr, intron: (rs4292900, rs16829225, rs4648936) (human)
RGD
PMID:19393422
RGD:5147411
NCBI chr 5:153,245,067...153,269,865
Ensembl chr 5:153,245,002...153,271,683
G
Il4
interleukin 4
treatment
ISO
associated with Asthma
RGD
PMID:12787306
RGD:7829803
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549
G
Mmp9
matrix metallopeptidase 9
ISO
RGD
PMID:23401274
RGD:8547880
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
G
Muc5ac
mucin 5AC, oligomeric mucus/gel-forming
treatment
IDA
RGD
PMID:23131200 PMID:19389874
RGD:7349403 , RGD:7364734
NCBI chr 1:206,293,717...206,326,006
Ensembl chr 1:206,293,869...206,326,006
G
Prkra
protein activator of interferon induced protein kinase EIF2AK2
severity
ISO
associated with Nasal Polyps
RGD
PMID:22961479
RGD:7777146
NCBI chr 3:81,982,669...82,002,028
Ensembl chr 3:81,982,673...82,001,525
G
Serpine1
serpin family E member 1
ISO
protein:increased expression:nasal mucosa (human)
RGD
PMID:21711960
RGD:6483796
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357
G
Tlr2
toll-like receptor 2
susceptibility
ISO
mRNA,protein:increased expression:paranasal sinus DNA:polymorphisms:: rs3804099,rs3804100(human)
RGD
PMID:22182736 PMID:21493395
RGD:7800733 , RGD:8552975
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:171,497,060...171,520,194
G
Tlr4
toll-like receptor 4
ISO
mRNA,protein:increased expression:paranasal sinus
RGD
PMID:22182736
RGD:7800733
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
G
Tnf
tumor necrosis factor
ISO
protein:increased expression:nasal cavity epithelium
RGD
PMID:11197112 PMID:20147558
RGD:7401169 , RGD:7401236
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
G
RT1-Bb
RT1 class II, locus Bb
ISO
DNA:polymorphisms, haplotypes:cds:HLA-DQB1*0301, HLA-DQB1*0302 (human)
RGD
PMID:15577839
RGD:5147654
NCBI chr20:4,598,475...4,604,118
Ensembl chr20:4,598,475...4,604,118
G
Alox5
arachidonate 5-lipoxygenase
ISO
RGD
PMID:16677242
RGD:5147463
NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:151,203,949...151,251,126
G
Apoa4
apolipoprotein A4
resistance
ISO
protein:increased expression:blood serum (human)
RGD
PMID:20810159
RGD:5685642
NCBI chr 8:55,435,779...55,438,160
Ensembl chr 8:55,434,168...55,438,164
G
Bdnf
brain-derived neurotrophic factor
severity
ISO
protein:increased expression:blood, nasal cavity epithelium
RGD
PMID:18266897
RGD:5144117
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657
G
Ccl5
C-C motif chemokine ligand 5
ISO
protein:increased expression:inferior turbinate, epithelium (human)
RGD
PMID:20459697
RGD:4891379
NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,738,651...68,824,884
G
Cma1
chymase 1
ISO
protein:increased expression:nasal mucosa, mast cell (human)
RGD
PMID:11549546
RGD:5128839
NCBI chr15:33,387,351...33,390,133
Ensembl chr15:33,387,351...33,390,133
G
Fga
fibrinogen alpha chain
ISO
RGD
PMID:21887273
RGD:5688767
NCBI chr 2:170,672,169...170,679,572
Ensembl chr 2:170,672,012...170,679,577
G
Glcci1
glucocorticoid induced 1
treatment
ISO
DNA:SNP: :rs37973
RGD
PMID:29981236
RGD:628359913
NCBI chr 4:37,274,271...37,601,898
Ensembl chr 4:37,529,364...37,599,802 Ensembl chr 4:37,529,364...37,599,802
G
Gsto1
glutathione S-transferase omega 1
ISO
protein:decreased expression;T lymphocyte:
RGD
PMID:21410266
RGD:5491008
NCBI chr 1:256,662,377...256,672,515
Ensembl chr 1:256,662,531...256,676,167
G
Icam1
intercellular adhesion molecule 1
ISO
protein:increased secretion:nasopharynx, secretion (human)
RGD
PMID:20128420
RGD:4145459
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
G
Ifngr1
interferon gamma receptor 1
ISO
DNA: SNP: Leu467Pro
RGD
PMID:12851715
RGD:6480431
NCBI chr 1:16,152,811...16,171,439
Ensembl chr 1:16,152,879...16,171,437
G
Il10
interleukin 10
treatment
ISO
RGD
PMID:19505388
RGD:7365025
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
G
Il18
interleukin 18
susceptibility no_association
ISO
DNA:SNPs:promoters, exon:multiple DNA:SNPs:promoters:multiple
RGD
PMID:12532106 PMID:12532106
RGD:8655871 , RGD:8655871
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286
G
Il4
interleukin 4
ISO
protein:increased expression:serum mRNA:increased expression:nose:
RGD
PMID:9237816 PMID:7551298
RGD:7829817 , RGD:8662960
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549
G
Kdr
kinase insert domain receptor
ISO
protein:increased expression:nasal cavity of mucosa:
RGD
PMID:17651148
RGD:8551771
NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,572,049...32,615,192
G
Mc1r
melanocortin 1 receptor
no_association
ISO
RGD
PMID:20357480
RGD:5687317
NCBI chr19:68,360,950...68,363,877
Ensembl chr19:68,360,950...68,363,877
G
Mmp9
matrix metallopeptidase 9
ISO
DNA:SNPs:promoter, intron, cds:-1590C>T, 2127G>T, p.R668Q (rs3918242, rs2274755, rs17577) (human)
RGD
PMID:22237587
RGD:8547819
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
G
Nod1
nucleotide-binding oligomerization domain containing 1
susceptibility
ISO
DNA:SNP: :rs2075817 (human)
RGD
PMID:16918516
RGD:5131519
NCBI chr 4:85,391,142...85,442,281
Ensembl chr 4:85,391,151...85,441,674
G
Nod2
nucleotide-binding oligomerization domain containing 2
susceptibility
ISO
DNA:polymorphisms:5'UTR/exon, exon:rs5743266, rs2066842 (human)
RGD
PMID:16008671
RGD:5131477
NCBI chr19:34,555,832...34,596,281
Ensembl chr19:34,555,832...34,722,846
G
Ptgs1
prostaglandin-endoperoxide synthase 1
ISO
protein:increased expression:respiratory system epithelium
RGD
PMID:19364335
RGD:5147461
NCBI chr 3:39,981,419...40,002,993
Ensembl chr 3:39,981,415...40,002,990
G
RT1-Bb
RT1 class II, locus Bb
susceptibility
ISO
DNA:polymorphism:cds:HLA-DQB1*05 (human) DNA:polymorphisms, haplotype:cds:HLA-DQB1*0301, HLA-DQB1*0501 (human)
RGD
PMID:22032123 PMID:9641569
RGD:7421561 , RGD:7421576
NCBI chr20:4,598,475...4,604,118
Ensembl chr20:4,598,475...4,604,118
G
Scgb1a1
secretoglobin family 1A member 1
ISO
mRNA, protein:decreased expression:nasal lavage fluid
RGD
PMID:15836756
RGD:5144234
NCBI chr 1:215,406,138...215,409,686
Ensembl chr 1:215,406,138...215,409,686
G
Tlr3
toll-like receptor 3
ISO
protein:decreased expression:bone marrow, blood, eosinophil (human)
RGD
PMID:19752565
RGD:5129130
NCBI chr16:53,554,916...53,572,321
Ensembl chr16:53,555,131...53,568,385
G
Tlr4
toll-like receptor 4
susceptibility
ISO
DNA:polymorphisms:cds:p.D299G, T399I (human)
RGD
PMID:18517079
RGD:4144192
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
G
Vegfa
vascular endothelial growth factor A
ISO
mRNA,protein:increased expression:nasal biopsies,nasal lavage fluid:
RGD
PMID:12633568
RGD:7483595
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all